Increasing The Therapeutic Potential Of Stem Cell Therapies For Critical Limb Ischemia
Open Access
- 27 January 2020
- journal article
- Published by Herald Scholarly Open Access in Journal of Stem Cells Research, Development & Therapy
- Vol. 6 (1), 1-7
- https://doi.org/10.24966/srdt-2060/100024
Abstract
Peripheral Arterial Disease (PAD) is a progressive, atherosclerotic disease that at its end stage, Critical Limb Ischemia (CLI), results in severely diminished limb perfusion and causes leg pain at rest, non-healing ulcers, and tissue gangrene. Many patients with CLI fail current medical and surgical therapies and thus are deemed "no option" and require limb amputation. Novel therapies to attempt limb salvage in these "no option" patients are needed. Stem cell therapy is one therapeutic angiogenic avenue that has been tested over the last 20 years. To date, clinical trials have shown promise but with only modest improvement and none demonstrated a significant decrease in amputation rates in those treated with stem cell therapy. Thus, recent investigations into improving stem cell therapy have been the focus of our laboratory and many others. This review aims to describe recent advances in increasing the therapeutic potential of stem cell therapies for CLI.Keywords
This publication has 64 references indexed in Scilit:
- Role for Substance P–Based Nociceptive Signaling in Progenitor Cell Activation and Angiogenesis During Ischemia in Mice and in Human SubjectsJournal of the American College of Cardiology, 2012
- Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdownAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Identification of E-selectin as a Novel Target for the Regulation of Postnatal NeovascularizationAnnals of Surgery, 2010
- Functional Mesenchymal Stem Cells Derived From Human Induced Pluripotent Stem Cells Attenuate Limb Ischemia in MiceJournal of the American College of Cardiology, 2010
- Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factorsProceedings of the National Academy of Sciences of the United States of America, 2009
- Comparison of Human Placenta- and Bone Marrow–Derived Multipotent Mesenchymal Stem CellsStem Cells and Development, 2008
- Aging and Disease as Modifiers of Efficacy of Cell TherapyCirculation Research, 2008
- Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1αJCI Insight, 2007
- Peripheral Arterial Disease in Patients With DiabetesJournal of Invasive Cardiology, 2006
- Clinical Outcome and its Predictors in 1560 Patients with Critical Leg IschaemiaEuropean Journal of Vascular and Endovascular Surgery, 1999